Success is achieved through
Focus, Speed & GRITT
We are designing the right Road Map using the right Technology, Science, Platform and Pipelines
Tissue-Specific Drug Delivery
We are developing targeted, tissue-specific drug delivery including small molecules, proteins and gene editing machinery including CRISPR/Cas9.
Gene therapy is also a key component of our development. This includes the development of site-specific CRISPR/Cas9 gene-editing platform.
Gene Repair Tool for DM2
Our aim is the DNA, the RNA and the Proteins involved in the etiology of DM2.
Development of 3rd generation Lentivirus specifically engeneered for tissue-specific load delivery
AAV gene editing delivery system
Guide RNA database
RNA silencing through AI technology, small molecule triggered endonuclease recruitment for targeted mRNA degradation
siRNA delivery for gene silencing
Input your search keywords and press Enter.